147 related articles for article (PubMed ID: 6454278)
1. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF.
Cockburn CG; de Beaufre-Apps RJ; Wilson J; Hardisty RM
Thromb Res; 1981 Feb; 21(3):295-309. PubMed ID: 6454278
[No Abstract] [Full Text] [Related]
2. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
Yoshioka A
Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
[No Abstract] [Full Text] [Related]
3. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
4. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
Switzer ME; McKee PA
J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
[TBL] [Abstract][Full Text] [Related]
5. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
[No Abstract] [Full Text] [Related]
6. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
7. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
Guisasola JA; Cockburn CG; Hardisty RM
Thromb Haemost; 1978 Oct; 40(2):302-15. PubMed ID: 153594
[No Abstract] [Full Text] [Related]
8. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
Switzer ME; Gordon HJ; McKee PA
Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
[TBL] [Abstract][Full Text] [Related]
10. Platelet von Willebrand factor: comparison with plasma von Willebrand factor.
Gralnick HR; Williams SB; McKeown LP; Krizek DM; Shafer BC; Rick ME
Thromb Res; 1985 Jun; 38(6):623-33. PubMed ID: 3927508
[TBL] [Abstract][Full Text] [Related]
11. An electroblotting technique for the detection of factor VIII/von Willebrand factor multimers in plasma.
Furlong BL; Peake IR
Br J Haematol; 1983 Apr; 53(4):641-53. PubMed ID: 6403025
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
[TBL] [Abstract][Full Text] [Related]
13. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
[No Abstract] [Full Text] [Related]
14. Electroblotting of factor VIII/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.
Batlle J; López Fernández MF; López Berges C; López Borrasca A
Br J Haematol; 1983 Sep; 55(1):195-6. PubMed ID: 6411111
[No Abstract] [Full Text] [Related]
15. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
[TBL] [Abstract][Full Text] [Related]
16. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
Andersen JC; Switzer ME; McKee PA
Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
[No Abstract] [Full Text] [Related]
17. Abnormal VIII-vWF patterns and hemolytic-uremic syndrome.
Howard MA; Firkin BG
Blood; 1985 Mar; 65(3):778. PubMed ID: 3918595
[No Abstract] [Full Text] [Related]
18. [Reduction of Willebrand activity in patients with chronic kidney failure].
Kazatchkine M; Sultan Y; Bariety J; Caen J
C R Acad Hebd Seances Acad Sci D; 1976 Jul; 283(3):287-9. PubMed ID: 825277
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
[TBL] [Abstract][Full Text] [Related]
20. Correlation between changes induced by venous occlusion on factor VIII-von Willebrand factor components and fibrinolytic activity.
Ponari O; Pini M; Poli T; Poti R; Dettori AG
Haemostasis; 1984; 14(2):179-83. PubMed ID: 6429015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
